selena gomez glp 1 weight loss: how it happened and the SIBO factor How Is This Even Possible?"

We recommend consulting your provider to potentially adjust your dosage, reviewing your nutrition plan, or increasing physical activity to restart your weight loss progress.

BMC Med (2020) 18(224):112

In 2024 the Food and Drug Administration added cardiovascular risk as a reason to be prescribed the GLP-1 drug Wegovy, grounded in results from a major trial that showed fewer heart attacks, strokes, and cardiovascular deaths in adults with obesity or overweight and established heart disease

Others feel jittery

Thats why careful monitoring is essential

Victoza also carries a black box warning for the risk of thyroid C-cell tumors based on animal studies, and while the development of medullary thyroid carcinoma in humans remains uncertain, this risk factor continues to be part of safety discussions